跳至主要内容
临床试验/NCT07591337
NCT07591337招募中不适用

The Association Between SNRK and Vascular Endothelial Aging

Tianjin Medical University1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2026年5月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
180
试验地点
1

研究概览

简要总结

Cardiovascular diseases pose a serious threat to public health, and their prevalence is on the rise year by year. Vascular aging is an independent risk factor for cardiovascular diseases, and endothelial cell senescence is an early event in vascular aging. Its occurrence can lead to endothelium-dependent vasodilation dysfunction, reduced vascular permeability, and the release of the senescence-associated secretory phenotype (SASP). These vascular pathological changes further damage the vascular media, leading to vascular remodeling and reduced compliance, accelerating the progression of atherosclerosis, and ultimately resulting in cardiovascular diseases such as coronary heart disease and hypertension. Recent research of the investigators has revealed that SNRK, a new member of the AMPK family of cellular energy sensors, plays a key regulatory role in vascular development. Based on this finding, the investigators propose the scientific hypothesis that SNRK responds to both physiological and pathological aging stimuli through differential mechanisms and regulates the process of endothelial cell senescence. In this study, the investigators will explore the correlation between SNRKAS and carotid vascular structure and endothelial function by measuring the levels of the SNRK upstream lncRNA (SNRKAS) in participants' peripheral blood, in conjunction with carotid ultrasound examinations. The findings will provide a solid scientific basis for elucidating new mechanisms underlying the onset and progression of vascular aging and for identifying novel therapeutic targets.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-80 years, with the capacity to make decisions independently or represented by an authorized legal guardian;
  • Able to provide complete personal information, medical history, and lifestyle history (e.g., smoking and alcohol consumption history);
  • No history of severe cardiovascular disease, and deemed eligible for inclusion by a physician.

排除标准

  • Women who are pregnant or may become pregnant;
  • Patients with a history of neurological disorders, tumors, severe cardiovascular or pulmonary disease, liver failure, kidney failure, or blood disorders;
  • Patients who have undergone carotid stenting, carotid endarterectomy, or other similar procedures, or who have unilateral carotid artery occlusion due to any cause;
  • Patients who have participated in another clinical trial within the past 4 weeks;
  • Individuals deemed unsuitable for this clinical trial by the investigators.

研究者

发起方
Tianjin Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xintong Ge

Professor

Tianjin Medical University

研究点 (1)

Loading locations...

相似试验